Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference21 articles.
1. Darrow JJ, Avorn J, Kesselheim AS. FDA approval and regulation of pharmaceuticals, 1983–2018. JAMA. 2020;323(2):164.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. A Cancer J Clin. 2020;70(1):7–30.
3. Park J, Look KA. Health care expenditure burden of cancer care in the United States. J Health Care Organ Provis Financing. 2019;56:004695801988069.
4. Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the united states: origins and prospects for reform. JAMA. 2016;316(8):858–71.
5. Gupta R, et al. Generic drug approvals since the 1984 Hatch-Waxman act. JAMA Intern Med. 2016;176(9):1391.